Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for STRATA Skin Sciences (SSKN) over the last 14 years, with Q3 2025 value amounting to $2.6 million.

  • STRATA Skin Sciences' Current Deferred Revenue rose 536.97% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 536.97%. This contributed to the annual value of $2.2 million for FY2024, which is 570.75% up from last year.
  • STRATA Skin Sciences' Current Deferred Revenue amounted to $2.6 million in Q3 2025, which was up 536.97% from $2.4 million recorded in Q2 2025.
  • STRATA Skin Sciences' Current Deferred Revenue's 5-year high stood at $3.8 million during Q3 2021, with a 5-year trough of $2.1 million in Q4 2023.
  • Over the past 5 years, STRATA Skin Sciences' median Current Deferred Revenue value was $2.4 million (recorded in 2024), while the average stood at $2.6 million.
  • In the last 5 years, STRATA Skin Sciences' Current Deferred Revenue skyrocketed by 13284.31% in 2021 and then tumbled by 2511.53% in 2023.
  • Over the past 5 years, STRATA Skin Sciences' Current Deferred Revenue (Quarter) stood at $3.3 million in 2021, then fell by 15.43% to $2.8 million in 2022, then dropped by 23.69% to $2.1 million in 2023, then increased by 5.71% to $2.2 million in 2024, then grew by 13.83% to $2.6 million in 2025.
  • Its Current Deferred Revenue stands at $2.6 million for Q3 2025, versus $2.4 million for Q2 2025 and $2.2 million for Q1 2025.